OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(22)
Publication Date
Release Date
2010
(4)
2025
(3)
2022
(3)
2021
(3)
2024
(2)
2023
(2)
2016
(1)
2015
(1)
2014
(1)
2011
(1)
2008
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Not available
S-EPMC4311405
|
biostudies-literature
Cite
Characterization of HPV and host genome interactions in primary head and neck cancers.
Not available
S-EPMC4217452
|
biostudies-literature
Cite
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Not available
S-EPMC4123233
|
biostudies-literature
Cite
Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response.
Not available
S-EPMC5013254
|
biostudies-literature
Cite
Effects of combination lipid therapy in type 2 diabetes mellitus.
Not available
S-EPMC2879499
|
biostudies-literature
Cite
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
Not available
S-EPMC4123215
|
biostudies-literature
Cite
Long-term effects of intensive glucose lowering on cardiovascular outcomes.
Not available
S-EPMC4083508
|
biostudies-literature
Cite
Effects of intensive glucose lowering in type 2 diabetes.
Not available
S-EPMC4551392
|
biostudies-literature
Cite
Effects of medical therapies on retinopathy progression in type 2 diabetes.
Not available
S-EPMC4026164
|
biostudies-literature
Cite
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets